United Kingdom· GB-APID-42659111000001108
Zilbrysq 23mg/0.574ml solution for injection pre-filled syringes
A zilucoplan product containing zilucoplan, registered in United Kingdom by UCB Pharma Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Zilucoplan is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AJ06 (zilucoplan), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Zilucoplan · ATC L04AJ06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Zilucoplan
- Manufacturer
- UCB Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AJ06
- ATC class
- Zilucoplan
- Defined daily dose
- 23 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05413787222346
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zilucoplan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaZILBRYSQUCB Pharma SA, Brusel
- BelgiumZilbrysq 16.6 mgUCB Pharma
- SpainZILBRYSQ 16,6 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAUcb Pharma
- FinlandZilbrysqUCB Pharma SA
- NetherlandsZilbrysq 16,6 mg oplossing voor injectie in een voorgevulde penUCB Pharma S.A.
- SwedenZILBRYSQ 16,6 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- PolandZilbrysqUCB Pharma S.A.
- United StatesZILBRYSQUCB, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zilbrysq
- Liechtenstein · Zilbrysq
- Norway · Zilbrysq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef6b1523-cb48-482e-be1b-2775557b19f9 GET /v1/drugs/ef6b1523-cb48-482e-be1b-2775557b19f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42659111000001108",
"desc": "Zilbrysq 23mg/0.574ml solution for injection pre-filled syringes (UCB Pharma Ltd)",
"form": "Solution for injection",
"vpid": "42668511000001102",
"source": "dmd",
"vtm_id": "42659711000001109",
"strength": "40 mg",
"substance": "Zilucoplan",
"ingredient": "Zilucoplan sodium",
"supplier_code": "2089701000001105"
}See everything about zilucoplan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.